Results 101 to 110 of about 40,304 (164)

HVIface: sequence-based deep learning for decoding human-virus protein-protein interfaces. [PDF]

Front Bioinform
Gupta KK, Vijayvargiya M, Paul G, Philip NS, Chauhan R.   +4 more
europepmc   +1 more source

HIV-1 Genetic Diversity and Transmitted Resistance to Integrase Strand Transfer Inhibitors in Benguela, Angola. [PDF]

Microorganisms
Godinho IS, Queirós G, Yefimenko L, Pereira FM, Piedade J.   +4 more
europepmc   +1 more source

Genetic Engineering of Lysogenic-Lytic Switch Genes Improves <i>Burkholderia</i> Phage Killing Efficacy. [PDF]

Int J Mol Sci
Khrongsee P, Doore SM, Somprasong N, Schweizer HP, Xiao YP, Subramaniam K, Mergia A, Tuanyok A.   +7 more
europepmc   +1 more source

HIV-1 Resistance to Dolutegravir in Benin: The Need to Improve and Strengthen Therapeutic Patient Education Strategies to Achieve the Third Objective 95 of UNAIDS 95-95-95 Target. [PDF]

Case Rep Infect Dis
Tchiakpe E, Diop-Ndiaye H, Osawe S, Toure-Kane C, Yessoufou A.   +4 more
europepmc   +1 more source

Letter to the editor: When do rare events become expected in HIV drug resistance? [PDF]

Euro Surveill
El-Khatib Z, Wessman M, Sönnerborg A, Fonager J, Zoufaly A, Leierer G, Assadian O, Benka B, Ndeikoundam Ngangro N, Kantor R.   +9 more
europepmc   +1 more source

Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study. [PDF]

J Antimicrob Chemother
Han N, Loosli T, Sauermann M, Çelikağ İ, Anderegg N, Baye BC, Bolton Moore C, Buzaalirwa L, Byakwaga H, Chimbetete C, Ebasone PV, Goodrich S, Huwa J, Kasozi C, Mafoua A, Massamba AC, Messou E, Minga A, Murenzi G, Muula G, Muyindike W, Naidoo SJ, Nsonde DM, Poda AG, Ramdé R, Semeere A, Singh L, Günthard HF, Egger M, Giandhari J, Lessells R, Kouyos RD.   +31 more
europepmc   +1 more source

Evidence of transfer of antimicrobial resistance genes from the porcine pathogen <i>Streptococcus suis</i> to human clinical isolates of <i>Streptococcus agalactiae</i> in a major pig-producing region of Spain. [PDF]

One Health
Uruén C, Lavilla MJ, Libante V, Marín CM, Rezusta A, Payot S, Arenas J.   +6 more
europepmc   +1 more source

The LEDGIN GS-9822 inhibits HIV-2 infection and enhances HIV-2 latency. [PDF]

Microbiol Spectr
Bruggemans A, Vansant G, Pellaers E, Van de Velde P, Christ F, Debyser Z.   +5 more
europepmc   +1 more source

R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation. [PDF]

S Afr J Infect Dis
Naidoo S.
europepmc   +1 more source

Treatment-Emergent Bictegravir Resistance in a Treatment-Naive Individual With HIV Infection: A Case Report. [PDF]

Cureus
Dubson I, Gaur A, Jose J, Andrews C, Gaballa A, McFarlane SI.   +5 more
europepmc   +1 more source